サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1412617

免疫蛍光アッセイ市場：製品タイプ、疾患、エンドユーザー別-2024-2030年世界予測

Immunofluorescence Assay Market by Products (Antibodies, Consumables & Accessories, Instruments), Type (Direct Immunofluorescence, Indirect Immunofluorescence), Disease, End-User - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 196 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
免疫蛍光アッセイ市場：製品タイプ、疾患、エンドユーザー別-2024-2030年世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 196 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

免疫蛍光アッセイ市場規模は2023年に39億8,000万米ドルと推計され、2024年には41億4,000万米ドルに達し、CAGR 5.51%で2030年には58億米ドルに達すると予測されます。

免疫蛍光アッセイの世界市場

主な市場の統計
基準年[2023］ 39億8,000万米ドル
予測年[2024］ 41億4,000万米ドル
予測年 [2030] 58億米ドル
CAGR（%） 5.51%
免疫蛍光アッセイ Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは免疫蛍光アッセイ市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、免疫蛍光アッセイ市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-免疫蛍光アッセイ市場の市場規模および予測は？

2-免疫蛍光アッセイ市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-免疫蛍光アッセイ市場における技術動向と規制の枠組みは？

4-免疫蛍光アッセイ市場における主要ベンダーの市場シェアは？

5-免疫蛍光アッセイ市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 世界中で慢性疾患の有病率が上昇
      • がん診断の改善に資金と予算を提供することで政府の支援を強化する
      • がんの早期発見と治療に対する意識の高まり
    • 抑制要因
      • 抗体の質の高い調査と高額な機器コストに伴う懸念
    • 機会
      • 製品の承認と有利な償還の増加
      • 免疫蛍光アッセイを使用する最新の方法のイントロダクション
    • 課題
      • 世界中で熟練したヘルスケア専門家が不足している
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 免疫蛍光アッセイ市場：製品別

  • 抗体
  • 消耗品と付属品
  • 機器
  • キット
  • 試薬

第7章 免疫蛍光アッセイ市場：タイプ別

  • 直接免疫蛍光法
  • 間接免疫蛍光法

第8章 免疫蛍光アッセイ市場：疾患別

  • 自己免疫疾患
  • がん
  • 心血管疾患
  • 感染症

第9章 免疫蛍光アッセイ市場：エンドユーザー別

  • 学術調査機関
  • 受託調査機関
  • 病院と診断センター
  • 製薬およびバイオテクノロジー企業

第10章 南北アメリカの免疫蛍光アッセイ市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域の免疫蛍光アッセイ市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカの免疫蛍光アッセイ市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第14章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Abnova Corporation
    • AESKU.GROUP GmbH & Co. KG
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • Bruker Corporation
    • Cell Signaling Technology, Inc.
    • Cellabs
    • Elabscience Biotechnology Inc.
    • Enzo Biochem, Inc.
    • J. Mitra & Co. Pvt. Ltd.
    • Maravai LifeSciences Inc.
    • Merck KGaA
    • Olympus Corporation
    • PerkinElmer Inc.
    • Thermo Fisher Scientific, Inc.
    • Zyagen, Inc.
  • 主要な製品ポートフォリオ

第15章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. IMMUNOFLUORESCENCE ASSAY MARKET RESEARCH PROCESS
  • FIGURE 2. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. IMMUNOFLUORESCENCE ASSAY MARKET DYNAMICS
  • FIGURE 7. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2023 VS 2030 (%)
  • FIGURE 8. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 10. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2023 VS 2030 (%)
  • FIGURE 12. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 14. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. IMMUNOFLUORESCENCE ASSAY MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. IMMUNOFLUORESCENCE ASSAY MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. IMMUNOFLUORESCENCE ASSAY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 6. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY CONSUMABLES & ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DIRECT IMMUNOFLUORESCENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY INDIRECT IMMUNOFLUORESCENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 15. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. IMMUNOFLUORESCENCE ASSAY MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 193. IMMUNOFLUORESCENCE ASSAY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 194. IMMUNOFLUORESCENCE ASSAY MARKET LICENSE & PRICING
目次
Product Code: MRR-501246437538

[196 Pages Report] The Immunofluorescence Assay Market size was estimated at USD 3.98 billion in 2023 and expected to reach USD 4.14 billion in 2024, at a CAGR 5.51% to reach USD 5.80 billion by 2030.

Global Immunofluorescence Assay Market

KEY MARKET STATISTICS
Base Year [2023] USD 3.98 billion
Estimated Year [2024] USD 4.14 billion
Forecast Year [2030] USD 5.80 billion
CAGR (%) 5.51%
Immunofluorescence Assay Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Immunofluorescence Assay Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Immunofluorescence Assay Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Immunofluorescence Assay Market, highlighting leading vendors and their innovative profiles. These include Abnova Corporation, AESKU.GROUP GmbH & Co. KG, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bruker Corporation, Cell Signaling Technology, Inc., Cellabs, Elabscience Biotechnology Inc., Enzo Biochem, Inc., J. Mitra & Co. Pvt. Ltd., Maravai LifeSciences Inc., Merck KGaA, Olympus Corporation, PerkinElmer Inc., Thermo Fisher Scientific, Inc., and Zyagen, Inc..

Market Segmentation & Coverage

This research report categorizes the Immunofluorescence Assay Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Products
    • Antibodies
    • Consumables & Accessories
    • Instruments
    • Kits
    • Reagents
  • Type
    • Direct Immunofluorescence
    • Indirect Immunofluorescence
  • Disease
    • Autoimmune Diseases
    • Cancer
    • Cardiovascular Diseases
    • Infectious Diseases
  • End-User
    • Academic & Research Institutes
    • Contract Research Organizations
    • Hospitals & Diagnostic Centers
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Immunofluorescence Assay Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Immunofluorescence Assay Market?

3. What are the technology trends and regulatory frameworks in the Immunofluorescence Assay Market?

4. What is the market share of the leading vendors in the Immunofluorescence Assay Market?

5. Which modes and strategic moves are suitable for entering the Immunofluorescence Assay Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Immunofluorescence Assay Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of chronic disease across the world
      • 5.1.1.2. Increasing government support by providing funds and budget in cancer diagnostics improvement
      • 5.1.1.3. Growing awareness of early detection and treatment of cancer
    • 5.1.2. Restraints
      • 5.1.2.1. Concern associated with quality research of antibodies and high instrumental cost
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing product approvals and favorable reimbursements
      • 5.1.3.2. Introduction of modern methods to use immunofluorescence assay
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of skilled healthcare professionals globally
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Immunofluorescence Assay Market, by Products

  • 6.1. Introduction
  • 6.2. Antibodies
  • 6.3. Consumables & Accessories
  • 6.4. Instruments
  • 6.5. Kits
  • 6.6. Reagents

7. Immunofluorescence Assay Market, by Type

  • 7.1. Introduction
  • 7.2. Direct Immunofluorescence
  • 7.3. Indirect Immunofluorescence

8. Immunofluorescence Assay Market, by Disease

  • 8.1. Introduction
  • 8.2. Autoimmune Diseases
  • 8.3. Cancer
  • 8.4. Cardiovascular Diseases
  • 8.5. Infectious Diseases

9. Immunofluorescence Assay Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Contract Research Organizations
  • 9.4. Hospitals & Diagnostic Centers
  • 9.5. Pharmaceutical & Biotechnology Companies

10. Americas Immunofluorescence Assay Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Immunofluorescence Assay Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Immunofluorescence Assay Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. Abnova Corporation
    • 14.1.2. AESKU.GROUP GmbH & Co. KG
    • 14.1.3. Becton, Dickinson and Company
    • 14.1.4. Bio-Rad Laboratories, Inc.
    • 14.1.5. Bruker Corporation
    • 14.1.6. Cell Signaling Technology, Inc.
    • 14.1.7. Cellabs
    • 14.1.8. Elabscience Biotechnology Inc.
    • 14.1.9. Enzo Biochem, Inc.
    • 14.1.10. J. Mitra & Co. Pvt. Ltd.
    • 14.1.11. Maravai LifeSciences Inc.
    • 14.1.12. Merck KGaA
    • 14.1.13. Olympus Corporation
    • 14.1.14. PerkinElmer Inc.
    • 14.1.15. Thermo Fisher Scientific, Inc.
    • 14.1.16. Zyagen, Inc.
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing